Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

932
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
932
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

184
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
184
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

81
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
81
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

265
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
265
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

967
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
967

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

User-centered design of a patient-generated health data mobile application for primary care visits for older adults with chronic pain.

JAMIA open·2026
Same author

How Many Veteran COVID-19 Cases Were There during the Pandemic?

Journal of medical virology·2026
Same author

Calculating the Probability that a Previously Susceptible Individual is Infected as a Function of Time Following Exposure to SARS-CoV-2.

Infectious diseases and therapy·2026
Same author

Automatic Placement Within a Hierarchical Clinical Decision Support Terminology.

Studies in health technology and informatics·2026
Same author

Care Coordination and Optimization in Geriatric Surgery (COGS): A Pilot Program to Improve Surgical Outcomes in Older Adults.

Journal of the American Geriatrics Society·2026
Same author

SARS-CoV-2 surveillance and vaccine effectiveness among dental healthcare workers during the omicron surge.

Scientific reports·2026

Related Experiment Video

Updated: Apr 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Methodological framework to identify possible adverse drug reactions using population-based administrative data.

Brian Sauer1, Jonathan Nebeker1, Shuying Shen1

  • 1Informatics, Decision Enhancement, and Surveillance (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, UT, UT 84148, USA.

F1000Research
|July 17, 2015
PubMed
Summary

This study found acetylcholinesterase inhibitors (AChEIs) are linked to gastrointestinal issues and potentially hematological adverse drug reactions (ADRs) in dementia patients. Further research is needed to confirm these drug safety signals.

Keywords:
Medicaidacetylcholinesterase inhibitorsadverse drug eventsadverse drug reactionsdrug safetypatient safetypharmacoepidemiologypost-marketing surveillancepropensity scores

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.3K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

Area of Science:

  • Pharmacovigilance
  • Clinical Epidemiology
  • Health Services Research

Background:

  • Dementia treatment often involves acetylcholinesterase inhibitors (AChEIs).
  • Identifying adverse drug reactions (ADRs) is crucial for patient safety.
  • Administrative data offers a valuable resource for pharmacovigilance.

Purpose of the Study:

  • To develop and apply a framework for detecting ADRs using administrative data.
  • To investigate ADRs associated with AChEI use in dementia patients.
  • To examine known, potential, and novel ADRs, including death.

Main Methods:

  • A cohort design linked drug utilization and medical claims data from Utah Medicaid.
  • Analysis included beneficiaries aged 50+ diagnosed with dementia.
  • Propensity-score matching and Cox-proportional-hazard regression were used to control for confounding.

Main Results:

  • AChEI treatment was associated with gastrointestinal episodes (HR: 2.02).
  • A higher risk of hematological episodes was observed with AChEI exposure (HR: 2.32).
  • No significant association was found for psychological disturbances, respiratory issues, hepatic episodes, or death.

Conclusions:

  • AChEI treatment is associated with gastrointestinal disturbances.
  • A potential signal for hematological ADRs emerged from this pilot study.
  • The developed framework can generate hypotheses for future drug safety investigations.